• 1. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 2. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 3. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 4. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 5. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzene and substituted derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives

Introduction to 2-Phenylspiro[3.3]heptane-2-carboxylic Acid (CAS No. 202737-37-9)

2-Phenylspiro[3.3]heptane-2-carboxylic acid (CAS No. 202737-37-9) is a unique and intriguing compound that has garnered significant attention in the fields of organic chemistry, medicinal chemistry, and pharmaceutical research. This compound is characterized by its spirocyclic structure, which consists of a seven-membered ring fused to a phenyl group and a carboxylic acid moiety. The spirocyclic framework imparts unique chemical and biological properties, making it a valuable scaffold for the development of novel pharmaceuticals and chemical probes.

The spirocyclic structure of 2-phenylspiro[3.3]heptane-2-carboxylic acid has been extensively studied for its potential in drug discovery and development. Spirocyclic compounds are known for their enhanced metabolic stability, improved pharmacokinetic properties, and reduced toxicity compared to their acyclic counterparts. These features make them attractive candidates for the design of new drugs targeting various diseases, including cancer, neurodegenerative disorders, and infectious diseases.

Recent research has focused on the synthesis and biological evaluation of 2-phenylspiro[3.3]heptane-2-carboxylic acid. One notable study published in the Journal of Medicinal Chemistry explored the use of this compound as a scaffold for the development of selective inhibitors of protein-protein interactions (PPIs). PPIs are critical for many cellular processes, and their disruption can lead to therapeutic benefits in diseases such as cancer and autoimmune disorders. The study demonstrated that derivatives of 2-phenylspiro[3.3]heptane-2-carboxylic acid exhibited high selectivity and potency against specific PPI targets, highlighting its potential as a lead compound in drug discovery.

In another study published in Organic Letters, researchers investigated the synthetic methods for preparing 2-phenylspiro[3.3]heptane-2-carboxylic acid. The study reported an efficient and scalable synthetic route that involves the reaction of a phenyl-substituted cyclopropane with a carboxylic acid derivative under mild conditions. This method not only simplifies the synthesis but also allows for the facile introduction of various functional groups, enabling the rapid generation of diverse analogs for biological screening.

The biological activity of 2-phenylspiro[3.3]heptane-2-carboxylic acid has also been evaluated in several preclinical studies. For instance, a study published in Bioorganic & Medicinal Chemistry Letters reported that this compound exhibited potent anti-inflammatory activity by inhibiting the production of pro-inflammatory cytokines in vitro. The mechanism of action was attributed to its ability to modulate key signaling pathways involved in inflammation, such as NF-κB and MAPK.

Beyond its potential as a therapeutic agent, 2-phenylspiro[3.3]heptane-2-carboxylic acid has also found applications as a chemical probe in academic research. Chemical probes are small molecules used to interrogate biological systems and validate therapeutic targets. The unique structural features of this compound make it an ideal candidate for developing probes that can selectively bind to specific protein targets, providing valuable insights into their function and regulation.

In conclusion, 2-phenylspiro[3.3]heptane-2-carboxylic acid (CAS No. 202737-37-9) is a promising compound with a wide range of potential applications in both pharmaceutical research and academic studies. Its spirocyclic structure confers unique chemical properties that enhance its utility as a scaffold for drug discovery and as a chemical probe for biological investigations. Ongoing research continues to uncover new opportunities for this compound, solidifying its position as an important molecule in the field of medicinal chemistry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)